Apple (AAPL) Lobbies Trump for China Chip Access

Apple seeks Trump administration approval to source DRAM from Pentagon-blacklisted CXMT as quadrupling memory prices force Mac and iPad price increases of up to 25%.

Apple has engaged U.S. Commerce Department officials since May 2026, seeking assurances CXMT will not be added to the restrictive Entity List
DRAM prices have quadrupled on AI-driven demand; CXMT chips cost 10–30% less than Apple's current Korean and U.S. suppliers
Congressional opposition is mounting, with the House China Committee chair calling the move a "grave mistake" benefiting PLA-linked firms

Lead

Apple (AAPL) is lobbying the Trump administration for permission to purchase dynamic random-access memory from ChangXin Memory Technologies (CXMT), China's fastest-growing chipmaker, in a campaign that has drawn sharp criticism from Congress and redrawn the front lines of U.S.-China semiconductor policy. The company has engaged officials at the U.S. Commerce Department since at least May 2026, seeking assurances that CXMT will not be placed on the Entity List — a designation that would effectively prohibit all commercial transactions. The push follows DRAM prices quadrupling on AI-driven data centre demand, forcing Apple to raise prices across its Mac and iPad lines by between 17% and 25% in a move that erased approximately $263 billion in market capitalisation in a single session.

What Happened

Apple's lobbying campaign, first reported by the Financial Times in late June, targets ChangXin Memory Technologies, a Hefei-based DRAM producer that holds an estimated 6% to 8% of the global market. Apple currently sources memory from Micron (MU), Samsung, and SK Hynix, but a structural allocation gap is forming as 15% to 20% of memory capacity earmarked for consumer electronics is being redirected to AI data centres by 2027. CXMT's ability to offer chips at a 10% to 30% discount to established suppliers makes it a commercially attractive alternative for a company managing acute cost pressure on its highest-volume products.

CXMT is also preparing a significant IPO on China's STAR Market, targeting approximately 29.5 billion yuan — roughly $4.3 billion — expected in the second half of 2026. A commercial relationship with Apple would materially lift the chipmaker's international profile ahead of that listing.

The Memory Supply Crisis

The scale of the pressure is visible in Apple's public disclosures. Management warned that memory costs will drive an "increasing impact" on the business beyond the June quarter, an unusually direct admission that signals the shortage is structural rather than transitory. DRAM prices climbed approximately 60% in 2025; forecasts call for a further 30% to 40% increase in 2026, with tight supply conditions expected to persist well into 2027.

Apple supply chain news in recent months has centred on the company's push to diversify iPhone assembly toward India — where roughly 25% of units are now produced — and Vietnam. But for advanced memory semiconductors, no comparable geographic alternative exists outside the Korean and U.S. incumbents whose allocations are increasingly contested by hyperscalers spending aggressively on AI infrastructure.

Geopolitical Dimension

The request occupies complex regulatory terrain. CXMT appears on the Defense Department's Section 1260H list of companies with alleged ties to China's People's Liberation Army. That designation restricts certain U.S. investment activities but does not itself prohibit American companies from sourcing components — a legal distinction central to Apple's strategy. Apple is seeking assurances CXMT will not be escalated to the Commerce Department's Entity List, which carries effectively prohibitive restrictions.

Congressional response has been immediate. Representative John Moolenaar, chairman of the House Select Committee on China, said working with a Chinese military-linked chipmaker would be "a grave mistake" and warned the arrangement could strengthen the PLA's semiconductor ecosystem. Senator Tom Cotton joined the criticism, while Senator Bernie Sanders targeted Apple Chief Executive Tim Cook directly, calling the decision to raise consumer prices an example of "corporate greed" from a company with substantial cash reserves.

Citi analysts struck a different tone, characterising Apple's commercial interest in China memory chips as a de facto global endorsement of CXMT's technological maturity — a framing that underscores how much the geopolitical weight of Chinese semiconductor progress now shapes ordinary procurement decisions.

Market Reaction

The Apple stock outlook 2026 has deteriorated sharply from its mid-year peak. AAPL closed at $281.74 on June 29, down approximately 11.7% from its all-time closing high of $315.20 reached on June 2. The single-day loss tied to the price-increase announcement — roughly $263 billion in market capitalisation — was the second-largest in Apple's history, reflecting investor concern over demand elasticity and margin compression. Shares recovered partially on the CXMT lobbying reports, gaining 1.89% to approximately $287 before pulling back, as markets weighed the prospect of meaningful cost relief against regulatory and political risk.

Micron (MU), whose position as an Apple memory supplier could be diluted if CXMT is approved, saw investor interest in the outcome; near-term observers note that CXMT's market share remains modest and Apple's volumes are unlikely to shift materially in the short term even with approval.

Strategic Context

The Apple China chip lobbying campaign reflects a broader tension embedded in U.S. technology supply chains. While the company has invested heavily in reducing its assembly dependence on China, the memory market has no equivalent geographic escape valve. Competitors selling into China's domestic market already access CXMT output at competitive pricing. Exclusion from that supply base imposes a structural cost disadvantage in the world's most price-sensitive consumer electronics markets.

Apple's approach — engaging regulators to shape blacklist enforcement rather than simply accepting its perimeter — may also establish a template for other large-cap technology companies navigating a growing list of commercially capable Chinese component suppliers operating under various levels of U.S. restriction.

Outlook

The White House has not publicly indicated a direction. A favourable ruling would give Apple negotiating leverage against its existing suppliers, margin relief extending into 2027, and a hedge against further supply-gap widening. Denial would leave the company managing a high-cost memory environment with fewer sourcing alternatives while Asian rivals absorb CXMT output freely. Either outcome will function as a benchmark for how the current administration weighs commercial petitions tied to Pentagon-listed Chinese technology firms — a question with implications across the semiconductor sector well beyond Apple supply chain news.

Mentioned tickers: AAPL, MU